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Abstract: The purpose of this cross-sectional study was to investigate hepatobiliary-related clinical
markers in Unites States adults (aged ≥ 20) exposed to lead using the National Health and Nutrition
Examination Survey (NHANES) 2007–2008 and 2009–2010 datasets. Clinical markers and occupation
were evaluated in 4 quartiles of exposure—0–2 µg/dL, 2–5 µg/dL, 5–10 µg/dL, and 10 µg/dL
and over—to examine how the markers and various occupations manifested in the quartiles.
Linear regression determined associations, and binary logistic regression predicted the likelihood of
elevated clinical makers using binary degrees of exposure set at (2 µg/dL, 5 µg/dL, and 10 µg/dL).
Clinical makers, and how they manifested between exposed and less-exposed occupations, were
explored in addition to how duration of exposure altered these clinical markers. In regression
analysis, Gamma-Glutamyl Transferase (GGT), total bilirubin, and Alkaline Phosphatase (ALP) were
positively and significantly associated with Blood lead level (BLL). Using binary logistic regression
models, at the binary 2 µg/dL level ALP, and GGT were more likely to be elevated in those exposed.
At 5 µg/dL level, it was ALP and GGT that were more likely to be elevated in those exposed
whereas at 10 µg/dL level, it was GGT that were more likely to be elevated in those exposed. In the
occupational analysis, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), GGT,
and ALP showed differences between populations in the exposed and less-exposed occupations.
Regarding Agriculture, Forestry and Fishing, duration of exposure altered AST, ALP, and total
bilirubin significantly (p < 0.05) while ALT and GGT were altered moderately significantly (p < 0.10).
With mining, duration of exposure altered AST and GGT moderately significantly, whereas in
construction duration in occupation altered AST, and GGT significantly, and total bilirubin moderately
significantly. The study findings are evidence of occupational exposure to lead playing a significant
role in initiating and promoting adverse hepatobiliary clinical outcomes in United States adults.
Keywords: lead exposure; hepatobiliary outcomes; heavy metals; occupational exposure
1. Introduction
Lead exposure among adults mainly occurs in the workplace within lead and zinc ore mining,
painting, and battery manufacturing industries [1]. Indeed, occupational exposure to inorganic
lead in Western countries occurs in mines and smelters, welding of lead painted metal, battery
manufacturing plants, and in the glass manufacturing industry [2]. Exposure to lead can also occur in
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community-based settings as is the case in El Paso, Texas, and Baltimore, Maryland. This is due to the
legacy of leaded gasoline and paint [3,4] in addition to industrial sources of exposure [5].
Lead is toxic and causes many adverse clinical outcomes in adults. It has no role in normal
biological function in humans but through several mechanisms can induce adverse health outcomes,
including adverse hepatobiliary outcomes. Furthermore, because lead is environmentally persistent,
populations can remain continuously exposed in areas where it was previously used. Sources and
extent of lead exposure have fallen dramatically over the past 30 years because of interventions such
as, lead content being reduced in gasoline, lead being limited in household paint, existing sources
of lead paint being contained, as well as lead being limited in the food canning process and in
industrial emissions and water. Despite that, lead continues to be an issue of public health significance
in the United States. It is biologically and environmentally persistent, making it hazardous as it
affects almost every organ system within the human body, including the hepatobiliary system [6–9].
Studies on the hepatotoxic effects of lead have demonstrated that exposure to lead alters cholesterol
metabolism, xenobiotic metabolism, and plays a role in hepatic hyperplasia [10]. Oxidative stress
is a major mechanism for the pathogenesis of lead induced toxicity. Hsu and Leon Guo [11]
determined that lead-induced oxidative stress contributes to the pathogenesis of lead poisoning
by disrupting the delicate pro-oxidant/antioxidant balance in the cells of mammals. Indeed, lead
exposure causes the generation of reactive oxygen species and modification of antioxidant defense
systems in occupationally exposed workers and animals and thus negatively impacts the liver. Autopsy
studies of lead-exposed patients have shown that a significant proportion of absorbed lead is stored
in the liver, giving credence to its disproportionate effects in the hepatobiliary system [12]. Studying
more about its effects on liver injury is thus an issue of public health importance as liver diseases
affects 3.9 million United States adults and there are 12 deaths per 100,000 people in the United States
from liver disease [13].
Liver and biliary system injury can be evaluated by examining clinical markers of liver damage.
Liver function test measuring hepatic enzymes such as Alanine Aminotransferase (ALT), Aspartate
Aminotransferase (AST), Alkaline Phosphatase Test (ALP), and Gamma-Glutamyl Transferase (GGT),
in addition to test measuring Total Bilirubin, help to assess the injury status of the liver and gallbladder,
but these clinical markers can also be elevated due to pathology in other organs; thus, an appropriate
differential diagnosis needs to be administered [14].
Aminotransferases are used to detect and monitor the progression and resolution of hepatocellular
injury [15]. AST catalyzes the conversion of aspartate and alpha-ketoglutarate to oxaloacetate and
glutamate [16]. AST is synthesized in the liver but is not specific to the liver: the kidney, heart, brain,
and muscles cells also synthesize smaller amounts of AST. ALT catalyzes the transfer of an amino
group to alpha-ketoglutarate from alanine in the alanine cycle, producing pyruvate and glutamate
in the process [16]. It is synthesized in the liver and is also usually present in low amounts in the
blood. With liver injury ALT tends to rise, as it is more specific to the liver than AST. Gamma-glutamyl
transferase (GGT) is a sensitive marker of hepatic inflammation. GGT, an enzyme that functions
in the gamma-glutamyl cycle, catalyzes the transfer of gamma-glutamyl functional groups from
molecules such as glutathione and is found not only in the liver but in other organ tissues, including
the kidney and pancreas. Elevated GGT levels in serum may indicate various liver pathologies,
including fatty liver disease, liver inflammation or hepatitis [17]. It can also be elevated due to
cholestasis. Alkaline phosphatase is found throughout the body, including in the liver, kidney, bone,
and digestive system, and is a good marker to test for hepatobiliary damage in addition to bone
cell dysregulation. Concentration of ALP is generally increased by cholestasis, injury to intestinal
epithelium, or damage to the biliary epithelium [16]. Total Bilirubin consists of unconjugated and
conjugated bilirubin. Unconjugated bilirubin is formed when heme is released from hemoglobin and is
converted to unconjugated bilirubin, the unconjugated bilirubin is then transported to the liver where
within the hepatocytes bilirubin, via a uridine diphosphoglucuronate-glucuronyltransferase (UDP-GT)
process, is conjugated with glucuronic acid. This process can be altered by various pathology along
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the pathway. Serum activity of these clinical markers are often a reflection of the physiological state of
the liver and their activity in blood often indicates the severity of cellular damage [12,14]. The effects
of lead on liver injury was examined in a study that looked at the effects of blood lead on plasma
levels of amino acids and serum liver enzymes among the exposed (100 industrial workers) and
controls (100-non industrial workers) in which they found liver enzymes to be significantly elevated in
industrialized workers as compared to non-industrialized workers [18].
Adult Blood Lead Epidemiology Surveillance (ABLES) operated under the Centers for Disease
Control and Prevention (CDC), is a state-based surveillance of adult BLLs in the United States.
In 1994, the rate of lead exposure to workers resulting in BLLs ≥ 25 µg/dL was 14 employed adults
per 100,000. In 2011, the rate was 6.4 employed adults per 100,000. The Occupational Safety and Health
Administration’s (OSHA) lead standards require that workers be removed from lead exposure sources
when BLLs≥ 50 µg/dL in the construction industry or 60 µg/dL in general industry, and in the context
of previous elevated exposure, workers are allowed to return to work when their BLLs are below
40 µg/dL [1]. It should be noted that the half-life of lead in blood is 35 days and 30 years in bone [19].
Blood lead level (BLL) is a reflection of acute exposure to lead while bone lead is a measure of chronic
exposure to lead. Using BLL to measure lead exposure is a validated method in both precision and
accuracy and a better method to test lead levels than urine lead measurements, which, because of
lead’s rapid clearance, makes it less accurate. Our study sought to examine the effects of lead on the
hepatobiliary system in the US general adult populations.
2. Materials and Methods
2.1. Hypothesis
In this study it was hypothesized that exposure to lead adversely affects hepatobiliary functions
via adversely affecting liver and biliary enzymes. In that respect this study sought to investigate the
effects of lead exposure on the studied participants by analyzing their AST, ALT, ALP, GGT, and total
bilirubin clinical markers. The analysis of BLLs and clinical markers within a sample of United States
adults determined the extent to which exposure to lead potentially altered the markers in individuals.
Lead’s impact on occupation was also explored to determine its effects on the clinical makers of interest
among those occupationally exposed to lead.
The sociodemographic, behavioral, and anthropometric covariates made it possible to statistically
control for factors associated with adverse hepatobiliary outcomes. It also made it possible to make
estimations about the contribution of lead to studied participants’ hepatobiliary clinical markers.
In all, it was hypothesized that being exposed to lead would be associated with elevated ALT,
AST, total bilirubin, ALP, and GGT.
2.2. Study Design
Research Design
Data from NHANES 2007–2010 were used to examine the association between lead and
hepatobiliary related markers ALT, AST, ALP, total bilirubin and GGT—in the general United States
adult population. The NHANES 2007–2010 survey was conducted by the CDC using a representative
sample of the U.S. noninstitutionalized civilian population. Altogether, 12,153 adult subjects ≥20 years
were included in this complex multistage, stratified cluster survey in 2007 through 2010, which after
factoring in sampling weights represented 217,057,187 people. Of the 12,153 participants, blood lead
was measured in 9781 adult subjects representing an estimated 182,052,299 people. For ALT values,
10,992 were measured; this represented 204,454,456 of the population. AST value levels were measured
for 10,991, representing 204,424,018 of the population whereas GGT value levels were measured for
10,996, which represented 204,525,189 of the population. With respect to total bilirubin, the levels
measured were for 9397, representing 170,044,349 of the population whereas ALP was measured for
10,996 adults, which represented 204,523,110 of the population.
Environments 2018, 5, 46 4 of 17
2.3. Data Collection
Recruitment
In NHANES, participants are selected using a complex sampling methodology with various clinical
makers collected every year from participants who are representative of the non-institutionalized
population. For this analysis, 4-year weights for individual probabilities drawn from biomarker data
sets were used following the NCHS web tutorial (NCHS 2010a). The sample weights for NHANES
2007–2010 were based on population estimates that incorporated the national census count. NHANES
2007–2010 consisted of a standardized questionnaire administered in the home by a trained interviewer
followed by a comprehensive physical examination at a Mobile Examination Center (MEC). The data
are freely available from the institution’s homepage.
A cross-sectional study, NHANES collects nationally representative data on health outcomes and
disease. Methods for demographic, clinical and survey data collection can be found at the NCHS’
website [20,21].
2.4. Quality Control
2.4.1. For Demographics
The computer-assisted personal interview (CAPI) software, that was used to gather the interview
data in NHANES 2007–2010, contained data edit and consistency checks which notified the interviewer
when the recorded data was erroneous. Information screens provided standardized descriptions of the
terminology and concepts that were used in the questionnaires for the interviewer. Data collection
was consistently reviewed by NHANES field officers and subsets of participants were re-contacted to
ensure accuracy. Finally, several interviews were audio-taped and reviewed by National Center for
Health Statistics (NCHS) and contractor staff to ensure quality.
2.4.2. For Hepatobiliary Markers
The NHANES 2007–2010 quality assurance/quality control (QA/QC) protocols fulfilled the 1988
Clinical Laboratory Improvement Act. Detailed instructions regarding QA/QC are found in the
NHANES Laboratory/Medical Technologists Procedures Manual (LPM). The General Documentation
of Laboratory Data file provides detailed QA/QC protocols.
2.4.3. Biomarkers and Biometric Data in This Study
The major biomarker of interest in this study is blood lead, which is representative of soft tissue
lead and a good measure of body burden and internal dose of lead [22]. BLLs can help one determine
the degree of exposure to lead at a snapshot in time. Other biomarkers of interest are AST, ALT,
GGT, ALP, and total bilirubin. These are hepatobiliary biomarkers. The hepatobiliary biomarkers
have been positively associated with exposure to lead in some studies while others have found no
association [18,23,24].
2.4.4. Instruments and Procedures
In the study, the biochemistry biomarkers were measured using a Beckman Synchron LX20,
Beckman UniCel® DxC800 Synchron (Brea, CA, USA) at Collaborative Laboratory Services and the
Roche Modular P chemistry analyzer at the University of Minnesota, MN, USA. Metal assays in whole
blood samples were conducted in the NHANES 2007–2010 at the Division of Laboratory Sciences,
National Center for Environmental Health (NCEH) of the CDC. Blood lead was determined by
inductively coupled plasma mass spectrometry (ICP-MS; CDC method no. ITB0001A).
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2.5. Data Management
Data management was done in accordance with the NHANES analytical guidelines relating to its
survey design and weighting [25]. The software Stata SE/15.0 (StataCorp, College Station, TX, USA)
was used for data management.
2.6. Analytical and Statistical Approaches
This study analyzed results from adults aged 20 and older. In portions of the study, analysis was
performed on those experiencing various degrees of exposure represented by BLLs in four quartiles;
0–2 µg/dL, 2–5 µg/dL, 5–10 µg/dL, 10+ µg/dL presented in this study as quartile 1, quartile 2,
quartile 3, and quartile 4 respectively, which represent thresholds typically and historically used in the
literature to represent elevated exposure. Association between lead and hepatobiliary outcomes were
explored using linear regression. Since the variables of interest were not normally distributed, natural
log transformation was used for dependent and independent variables in regression analysis.
Both continuous and categorical data were analyzed. For linear regression, all independent
variables were examined as continuous variables. The covariates of interest (gender, BMI, ethnicity,
and age), and consumption of alcohol (those who had taken at least 12 alcoholic drinks in the past year)
and smoking habits, were adjusted for to determine leads impact on the clinical markers of interest.
In the binary logistic regression models, the dependent variable was categorical for lead exposure
at the 2, 5, and 10 µg/dL levels. Statistical analyses were performed using Stata SE/15.0 (StataCorp,
College Station, TX, USA) as the software allowed for adjustment for clusters and strata of the complex
sample in addition to incorporating the sample weight in order to generate estimates for the total
noninstitutionalized civilian population of the United States.
In addition, occupational analysis was performed examining the mean difference between the
clinical markers of occupationally exposed workers as compared to occupationally less exposed
workers. Finally, the mean levels of the clinical markers of interest were explored in durations of
0–5 years, 5–10 years, and over 10 years to see how the markers manifested over various time periods.
A p-value of <0.05 was considered significant while a value of <0.10 was considered moderately
significant. Excel 2016 was used to generate charts/figures.
3. Results
3.1. Sociodemographic, Anthropometric and Clinical Variables/Data
The objective of this section is a presentation of the results on lead exposure with regards to
the participant sociodemographic characteristics, and those of their clinical and anthropometric
information. The results of the sociodemographic information will be presented first. In presenting the
results of participants’ sociodemographic information; gender and ethnicity, as well as their occupation
are presented.
3.1.1. Gender
The results (in percentages) of the different gender categories and quartiles of exposure in the
study data are shown in Table 1 below with the percent standard error (SE%), a measure of the precision
of the mean, shown in brackets. As can be seen, males represent a larger percent of those in the highest
exposure groups while females represent a larger percent of the lowest exposure group.
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Table 1. Gender and quartiles of exposure.
Lead Exposure Male% (SE%) Female% (SE%)
N 5858 6295
Quartile 1 (0–2 µg/dL) 67.8% (1.2) 82.5% (0.9) ****
Quartile 2 (2–5 µg/dL) 27.8% (1.0) ** 16.6% (0.8)
Quartile 3 (5–10 µg/dL) 3.7% (0.3) *** 0.9% (0.1)
Quartile 4 (10+ µg/dL) 0.7% (0.2) * 0.1% (0.0)
Total 100% 100%
* p < 0.05 Male making up a significantly larger proportion than Female in this exposure group; *** p < 0.05 Male
making up a significantly larger proportion than Female in this exposure group; ** p < 0.05 Male making up
a significantly larger proportion than Female in this exposure group; **** p < 0.05 Female making up a significantly
larger proportion than Male in this exposure group.
3.1.2. Ethnicity
The ethnic groups identified in the data were Mexican American, Non-Hispanic White,
Non-Hispanic Black, Other Hispanic, and Other Race (including multi-racial). Percentages representing
the various quartiles of exposure are shown in Table 2 below. As can be seen, among Mexican-Americans,
a larger percentage are in the highest exposure group (quartile 4) as compared to other ethnic
groups. While in the second largest exposure group, Blacks and Mexican-Americans make up a larger
percentage as compared to other ethnic groups.
Table 2. Ethnicity and quartiles of exposure.
Lead Exposure MexicanAmerican% (SE%)
Other Hispanic%
(SE%)
Non-Hispanic
White% (SE%)
Non-Hispanic
Black% (SE%)
Other Race—Including
Multi-Racial% (SE%)
N 1032 600 8342 1377 802
Quartile 1 72.0% (1.9) 80.7% (2.1) +++ 76.9% (1.2) ***** 71.5% (1.3) 66.7% (3.4)
0–2 µg/dL
Quartile 2 23.2% (1.4) ++ 17.3% (2.4) 21.1% (1.1) 24.4% (1.2) + 29.7% (2.9) ****
2–5 µg/dL
Quartile 3 3.7% (0.7) ** 1.6% (0.3) 1.8% (0.2) 3.7% (0.5) *** 2.9% (0.8)
5–10 µg/dL
Quartile 4 1.0% (0.3) *,# 0.4% (0.3) 0.2% (0.1) 0.3% (0.1) 0.8% (0.5)
10+ µg/dL
Total 100% 100% 100% 100% 100%
+p < 0.05 significant difference between Non-Hispanic Black and Other Hispanic and non-Hispanic White; ++ p < 0.05
significant difference between Mexican-American and Other Hispanic; +++ p < 0.05 significant difference between
Other Hispanic and Mexican-American, non-Hispanic Black and Other Race-including multi-racial; * p < 0.05
significant difference between Mexican American and Non-Hispanic white; ** p < 0.05 significant difference
between Mexican American and other Hispanic and non-Hispanic white; *** p < 0.05 significant difference between
non-Hispanic Black and Other Hispanic, non-Hispanic White; **** p < 0.05 significant difference between other race-
including multiracial and Mexican American, Other Hispanic, and non-Hispanic white; ***** p < 0.05 significant
difference between non-Hispanic White and Mexican-American, Non-Hispanic Black and Other Race-Including
Multiracial; # p < 0.10 moderately significant difference between Mexican American and Non-Hispanic Black.
3.1.3. Occupation
Longevity in Jobs (Occupation One Had Spent the Most Time in)
The longevity of employment in a job was also taken into consideration to see how it manifested
across different quartiles of exposure. Table 3 summarizes the results. As can be seen Agriculture,
Forestry, and Fishing, Mining, and Construction make up a large percentage of the highest
exposure groups.
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Table 3. Longest held occupation and quartiles of exposure.
Occupation Quartile 1 Quartile 2 Quartile 3 Quartile 4
0–2 µg/dL (SE%) 2–5 µg/dL (SE%) 5–10 µg/dL (SE%) 10+ µg/dL (SE%)
Accommodation, Food Services 80.8% (2.7) 17.7% (2.7) 1.4% (0.5) 0.2% (0.2)
Agriculture, Forestry, Fishing 53.2% (3.5) 41.8% (3.9) ** 4.8% (2.3) **** 0.1% (0.1)
Arts, Entertainment, Recreation 82.4% (4.0) *** 16.8% (3.9) 0.8% (0.8) -a
Construction 58.2% (3.0) 35.4% (2.7) ** 5.1% (1.1) **** 1.3% (0.5) *
Education Services 69.1% (3.2) 29.6% (3.1) 1.4% (0.5) -a
Finance, Insurance 78.0% (3.4) 19.9% (3.4) 1.8% (1.6) 0.2% (0.2)
Health Care, Social Assistance 78.1% (2.4) 20.0% (2.5) 1.8% (0.6) 0.01% (0.0)
Information 71.7% (4.3) 27.6% (4.2) 0.2% (0.2) 0.5% (0.5)
Management/Waste Services 77.7% (4.3) 21.1% (4.3) 1.2% (0.9) -a
Manufacturing: Durable Goods 66.3% (2.3) 28.6% (2.1) 4.4% (0.7) 0.8% (0.5) *
Manufacturing: Non-Durable Goods 68.6% (2.6) 28.4% (2.4) 2.8% (0.8) 0.3% (0.2)
Mining 53.7% (9.9) 38.7% (7.3) ** 7.6% (2.9) **** -a
Other Services 69.1% (5.4) 28.9% (5.3) 2.0% (2.0) -a
Private Households 80.4% (5.6) *** 19.6% (5.6) -a -a
Professional, Technical Services 87.6% (3.1) *** 11.9% (3.1) 0.5% (0.4) -a
Public Administration 68.8% (3.2) 29.4% (3.1) 1.0% (0.6) 0.8% (0.8)
Real Estate, Rental, Leasing 83.0% (5.4) *** 13.8% (4.8) 2.7% (1.8) 0.4% (0.4)
Retail Trade 79.1% (2.5) 18.3% (2.2) 2.0% (0.7) 0.5% (0.5)
Transportation, Warehousing 62.2% (4.5) 34.4% (4.3) 3.5% (1.1)
Utilities 51.6% (8.4) 43.1% (8.2) ** 5.4% (4.5) **** -a
Wholesale Trade 75.0% (4.0) 18.8% (3.5) 6.1% (2.2) -a
-a, no data; * p < 0.05 for Construction and Manufacturing Durable Goods representing a significantly larger
proportion of exposure category as compared to many other industries in the category such as Finance, Insurance,
and Health Care, Social Assistance; ** p < 0.05 of Agriculture, Forestry, Fishing, Mining, Utilities and Construction
representing a significantly larger proportion of exposure category as compared to many other industries in exposure
category such as Professional, Technical Services and Arts, Entertainment, Recreation; *** p < 0.05 Real Estate,
Rental, Leasing; Professional, Technical Services; Arts, Entertainment, Recreation, Private Households representing
a significantly larger proportion of exposure category as compared to many other industries in this category, such as
agriculture and construction; **** p < 0.05 for Agriculture, Forestry, Fishing, Mining, Utilities, and Construction
representing a significantly larger proportion of exposure category as compared to many other industries in the
exposure category, such as Information and Professional, Technical Services.
3.2. Age, BMI, and Clinical Markers
The objective of this section is a presentation of the results of the clinical and anthropometric
markers. Specifically, this study section will explore lead’s relationship with, age, BMI, AST, ALT, ALP,
GGT, and Total Bilirubin. Information by degree of exposure is presented in Table 4. As can be seen,
higher exposure resulted in elevated hepatobiliary clinical markers.
Table 4. Age and BMI and quartiles of exposure.
Variables
Quartile 1 Quartile 2 Quartile 3 Quartile 4
0–2 µg/dL 2–5 µg/dL 5–10 µg/dL 10+ µg/dL
BLL 1.09 (0.01) 2.78 (0.02) 6.40 (0.10) 16.11 (1.40)
Age * 44.25 (0.32) 56.05 (0.54) 54.77 (1.13) 47.56 (2.56)
BMI 25.79 (0.17) 25.91 (0.18) 26.06 (0.49) 26.40 (0.92)
AST **** 25.67 (0.20) 27.17 (0.38) 27.34 (1.04) 31.50 (5.30)
ALT 25.87 (0.24) 26.21 (0.46) 26.23 (1.27) 28.84 (2.09)
ALP ** 65.68 (0.39) 71.72 (0.56) 77.42 (1.95) 80.60 (4.07)
GGT *** 26.54 (0.40) 33.10 (0.92) 40.70 (3.77) 41.49 (4.99)
Total Bilirubin 0.77 (0.01) 0.78 (0.01) 0.81 (0.03) 0.84 (0.07)
* Significant difference between quartile 1 and 2, 3; ** p < 0.05 significant difference between quartile 1 and 2, 3;
*** p < 0.05 significant difference between quartile 1 and 2, 3; **** p < 0.05 significant difference between
quartile 1 and 2.
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3.3. Association of BLL with Clinical Markers of Interest of All Adults
All variables were adjusted for age, gender, race/ethnicity, BMI, alcohol consumption, and
smoking. The associations of BLL, presented as the natural log of BLL (lnBPb), and the hepatobiliary
clinical variables are presented in Table 5 below.
Table 5. Associations of BLL hepatobiliary-related markers of interest.
Variables lnBPb Adjusted (95% CI) + p Value
AST 0.023 (−0.057, 0.103) 0.568
ALT −0.035 (−0.083, 0.013) 0.147
ALP 0.264 (0.206, 0.321) 0.0001
GGT 0.073 (0.046, 0.099) 0.0001
Total Bilirubin 0.079 (0.025, 0.133) 0.004
+ Adjusted for age, gender, race/ethnicity, BMI, alcohol consumption and smoking.
3.4. Binary Logistic Regression Analysis of Clinical Makers
Binary logistic regression analysis was performed to examine the factors associated with BLLs at
different levels of exposure. Detailed results of hepatobiliary related factors are shown in Table 6.
Table 6. Logistic regression analysis BLL binary at 2 µg/dL, 5 µg/dL, and 10 µg/dL level.
Variable in Model
Binary at 2 µg/dL Binary at 5 µg/dL Binary at 10 µg/dL
Adj. Odds Ratio (95% CI) + Adj. Odds Ratio (95% CI) + Adj. Odds Ratio (95% CI) +
ALT 0.858 (0.707, 1.04) 0.849 (0.529, 1.36) 1.36 (0.677, 2.74)
AST 0.982 ( 0.736, 1.31) 1.12 (0.568, 2.21) 2.10 (0.520, 8.48)
ALP 1.93 (1.42, 2.612) * 2.90 (1.18, 7.08) * 4.23 (0.576, 31.1)
GGT 1.24 (1.08, 1.42) * 1.48 (1.12, 1.95) * 2.19 (1.34, 3.56) *
Total Bilirubin 1.05 (0.770, 1.42) 1.36 (0.644, 2.85) 2.43 (0.543, 10.9)
+ Adjusted for age, gender race/ethnicity and BMI and alcohol consumption and smoking. * p < 0.05.
3.5. Occupational Exposure to Lead
Occupational exposure to lead was explored since most adults are exposed to lead at the workplace.
Firstly, it was determined which three occupations had the highest and lowest BLLs at the occupation
of longest duration, as BLL is a marker of the exposure level. This was done to examine how the
clinical makers of interest manifested in those in high exposure occupations when compared to those
in low exposure occupations. Finally, the duration of work was examined in time intervals of 0–5 years,
5–10 years, and over 10 years to see how length of time at a lead exposed job may alter clinical outcomes
of interest.
Occupations Providing Highest Exposure
The occupations providing a high level of exposure as measured by mean BLLs were:
(a) Agriculture, Forestry & Fishing 2.19 µg/dL (SE = 0.118); (b) Mining 2.33 µg/dL (SE = 0.34);
and (c) Construction 2.39 µg/dL (SE = 0.12). The occupation providing the lowest levels of exposure
as measured by mean BLLs were: (a) Professional, Scientific, Technical Services 1.35 µg/dL (SE = 0.05);
(b) Private Household 1.35 µg/dL (SE = 0.11); and (c) Arts, Entertainment, Recreation 1.33 µg/dL
(SE = 0.11). These occupations were examined to see the effects of long term exposure on makers
of interest via looking at those who had these jobs as their job of longest duration. Figure 1 below
illustrates the findings.
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Figure 1. Occupation and Lead Exposure. * Significant difference between high exposure occupations
as compared to low exposure occupations.
It is observed that for the high exposure occupations, the mean AST levels were as follows: for
Agriculture, Forestry & Fishing, it was 28.96 U/L (SE = 2.44); for Mining, the level was 28.02 U/L
(SE = 1.29); and for Construction, it was 27.86 U/L (SE = 0.65). For the low exposure occupations,
the mean AST levels were: Professional Scientific, Technical Services, 25.81 U/L (SE = 1.11); Private
Household, 25.46 U/L (SE = 1.30); and Arts Entertainment, Recreation, 29.40 U/L (SE = 2.16). The mean
AST levels are shown in Figure 2 below.
Figure 2. Occupation and Mean AST Levels. * Moderately Significant difference between Construction
and Private Households.
For the high exposure occupations, the following mean ALT level were obtained. For Agriculture,
Forestry & Fishing the level was 2.67 U/L (SE = 2.54); for Mining it was 28.75 U/L (SE = 1.66); and
for Construction, the level was 28.63 U/L (SE = 0.85). For the low exposure occupations, the mean
ALT levels were: Professional Scientific, Technical Services 23.58 U/L (SE = 0.87); Private Household
24.19 U/L (SE = 1.87); and Arts Entertainment, Recreation 27.21 U/L (SE = 2.41). The mean ALT levels
are shown in Figure 3 below.
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Figure 3. Occupation and Mean ALT Levels. * Moderately significant difference between Agriculture
and Professional Scientific, Technical Services. # Significant difference between Mining and Professional
Scientific, Technical Services. @ Moderately significant difference between Mining and Private
Households. + Significant difference between Construction and Professional Scientific, Technical
Services, and Private Households.
With respect to the high exposure occupations, the following results were obtained for mean GGT
levels. For Agriculture, Forestry & Fishing the GGT level was 30.36 U/L (SE = 1.82); it was 37.41 U/L
(SE = 2.25) for Mining; and 34.75 U/L (SE = 1.97) for Construction. For the low exposure occupations,
the mean GGT levels were: Professional Scientific, Technical Services 24.65 U/L (SE = 2.10); Private
Household 30.30 U/L (SE = 3.95); and Arts Entertainment, Recreation 27.44 U/L (SE = 3.54). The mean
GGT levels are shown in Figure 4 below.
Figure 4. Occupation and Mean GGT Levels. * Significant difference between Agriculture Forestry,
Fishing and Professional Scientific, Technical Services. + Significant difference between Mining and
Professional Scientific, Technical Services and Arts, Entertainment Recreation. # Significant difference
between construction and professional.
Results of the mean total bilirubin levels for the high exposure and low exposure occupations were
also obtained. For the high exposure occupations, the results were as follows: for Agriculture, Forestry
& Fishing, it was 0.79 mg/dL (SE = 0.02); for Mining, the mean total bilirubin level was 0.74 mg/dL
(SE = 0.03); and for Construction it was 0.79 mg/dL (SE = 0.03). For the low exposure occupations,
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the mean total bilirubin levels were: Professional Scientific, Technical Services, 0.80 mg/dL (SE = 0.04);
Private Household, 0.73 mg/dL (SE = 0.04); and Arts Entertainment, Recreation, 0.80 mg/dL (SE = 0.04).
The mean total bilirubin levels are shown in Figure 5 below.
Figure 5. Occupation and Total Bilirubin Levels.
Results of the mean Alkaline Phosphatase (ALP) levels for the high exposure and low exposure
occupations were also obtained. For the high exposure occupations, the results were as follows: for
Agriculture, Forestry & Fishing the ALP level was 72.66 U/L (SE = 1.67); for Mining, it was 66.02 U/L
(SE = 2.00); and for Construction, the level was 71.13 U/L (SE = 1.06). For the low exposure occupations,
the mean Alkaline Phosphatase levels were: Professional Scientific & Technical Services, 64.01 U/L
(SE = 1.73); Private Household, 73.47 U/L (SE = 3.12); and Arts Entertainment & Recreation, 62.68 U/L
(SE = 2.05). The mean Alkaline Phosphatase levels are shown in Figure 6 below.
Figure 6. Occupation and Mean ALP Levels. * Significant difference between agriculture and
professional and arts. + Significant difference between construction and professional and arts.
Finally, the duration of exposure was explored. Length of exposure was examined in three
intervals, 0–5 years of work, 5–10 years of work, and over 10 years of work in the three high exposure
occupations of interest in order to better understand the impact of longevity of exposure on the markers
of interest. Table 7 reports the mean clinical markers of interest and corresponding standard error (SE).
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Table 7. Longevity in occupation and clinical markers.
Time
Interval Occupation BLL (SE) AST (SE) ALT (SE) ALP (SE) GGT (SE)
Total
Bilirubin
(SE)
0–5 years Construction 1.58 (0.76) 25.54 (0.81) 26.97 (1.61) 73.62 (2.56) 28.40 (2.79) 0.86 (0.07)
5–10 years Construction 2.71 (0.69) 27.72 (1.38) 30.72 (2.70) 71.10 (1.82) 35.78 (5.27) 0.71 (0.04)
10+ years Construction 2.53(0.27) @, M1 28.49 (0.78) @ 28.60 (0.90) 70.49 (1.29) 36.17 (2.30) @ 0.79 (0.03) M2
0–5 years Mining 1.05 (0.43) 23.03 (2.19) 22.61 (2.60) 66.81 (3.66) 26.47 (1.42) 0.81 (0.16)
5–10 years Mining 1.61 (0.28) 33.27 (4.93) M 35.62 (6.34) 66.92 (2.74) 50.77 (11.1) M1 0.71 (0.08)
10+ years Mining 2.57 (0.38) +, @ 27.04 (1.57) 27.43 (2.38) 65.72 (1.98) 34.75 (3.33) 0.74 (0.03)
0–5 years Agriculture 1.72 (0.38) 21.65 (0.51) 23.89 (2.40) 61.96 (4.07) 24.39 (3.52) 0.64 (0.05)
5–10 years Agriculture 2.18 (0.48) 22.21 (0.90) 21.86 (2.52) 69.82 (6.15) 24.55 (3.56) 0.62 (0.06)
10+ years Agriculture 2.25 (0.12) 30.89 (3.20)
@,
*
30.27 (3.25)
M2
74.52 (1.92)
@ 31.89 (M1,2)
0.83 (0.03)
@, +
@ Significantly different from 0–5 years to 10+; * Significantly different 5–10 years to 10+; + Significantly difference
0–5 to 5–10; M moderately significant difference between 0–5 years and 5–10 years; M1 moderately significant
difference between 0–5 years and 10+ years; M2 moderately significant difference between 5–10 years to 10+ years.
4. Discussion
4.1. On Lead and Occupation
Cognizant of the fact that lead exposure in adults most commonly occurs in the workplace and
industries such as the construction industry, which has historically been a source of lead exposure
among adults [26], this study sough to explore occupation and its connection with lead exposure by
examining participant hepatobiliary markers in occupations. The results indicated that the quartile
of exposure was related to occupation, with occupations such as mining and construction making
up a significantly larger proportion of the highest exposure quartiles (10+ µg/dL) while occupations
such as education made up a significantly larger proportion of the lowest quartiles of exposure
(0–2 µg/dL). In subsequent analysis it was determined that the occupations providing the most
exposure, as measured by BLLs in adults, were the Construction Industry; Agriculture Forestry &
Fishing; and Mining. The occupations with the least exposed population were: Professional, Scientific
and Technical Services; Private Household; and Arts, Entertainment and Recreation. These industries
were examined to see how the clinical markers of interest varied between the high exposure occupations
and the lower exposure occupation.
In comparing high exposure occupations to low exposure occupations, the mean BLL’s were
significantly higher when comparing the three high exposure occupations to the three low exposure
occupations, affirming that some occupations predispose workers to lead exposure. For example,
those in Construction had significantly elevated blood pressure in the highest quartile of exposure as
compared to those in the less-exposed occupations such as Education. This is significant as it offers
a means to perform targeted intervention toward higher exposure occupations. This exposure and how
it manifests cannot only be tied to occupation and may also include behavioral patterns associated
with occupations which may accelerate the negative impact of lead on the hepatic and biliary system.
Some of these behaviors, including smoking and alcohol use, were adjusted for in this study in order
to offer more insight into the extent to which lead may be inducing liver damage. In addition gender
and age are also potential factors altering the manifestation of these enzymes [27], hence the need to
adjust for them.
For AST, a clinical marker of liver injury, there was a significant difference in the mean levels
between those in Construction when compared with those in Private Households, potentially indicating
that those in a lead exposed industry experience worse outcomes than those in a less exposed industry.
For ALT, there was a significant difference in the mean levels between those in the Mining occupation
and those in the Professional, Scientific & Technical Services, also supporting this conclusion. There was
also a moderately significant difference in the mean levels between those in Mining and those in Private
Households. Also, a moderately significant difference between the populations in Agriculture Forestry
& Fishing compared with those in Professional Scientific and Technical services was discovered.
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Thus, those lead exposed industries seem to experience elevated liver injury as compared to those in
less lead exposed industries.
With respect to GGT, there was a significant difference between Agriculture, Forestry & Fishing
when compared to Professional Scientific, Technical Services. In addition, there was a significant
elevation in the mean level of those in Mining when compared to those in Professional Scientific &
Technical Services, and Arts, Entertainment & Recreation. Finally, there was a significant elevation
in construction when compared to Professional, Scientific, and Technical Services, which confirmed
the pattern. For Alkaline Phosphatase, there was a significant elevation between Agriculture, Forestry
& Fishing, and Construction when compared to Professional Scientific, Technical Services, and Arts,
Entertainment, and Recreation, also confirming lead’s potential impact on the hepatic and biliary system.
Finally, in the longest held occupations, a marker of long term exposure to lead due to occupation,
results for Construction demonstrated that mean BLLs were significantly elevated from the 0–5-year
working period when compared to the 10 plus year working period, while it was moderately elevated
from the 0–5 to 5–10-year period. In Mining, BLLs were significantly elevated from the 0–5-year to the
10+ year period and from the 0–5-year period to the 5–10-year period. Hinting at the potential adverse
outcomes over time with hepatobiliary injury becoming more severe over time.
Regarding duration of exposure, AST was moderately elevated from the 0–5 to the 5–10-year
period for Mining. For Construction, AST was significantly elevated from the 5–10-year to the 10+ year
period with Agriculture, Forestry & Fishing showing a significant elevation from 0–5 to 10+ years and
5–10 to 10+ years. For ALT Agriculture, Forestry & Fishing showed a moderately significant elevation
from 5–10 to 10+ years. For ALP, Agriculture, Forestry & Fishing showed a significant increase from
0–5 to 10+ years. For GGT there was a moderately significant elevation from 0–5 to 10+ years and
5–10 to 10+ years for Agriculture, Forestry & Fishing. For Mining, there was a moderately significant
elevation from 0–5 to 10+ years whereas for Construction there was a significantly elevated mean from
0–5 to 10+ years. Finally, for total bilirubin there was a significant elevation from 0–5 to 10+ years and
from 0–5 to 5–10 years for Agriculture Forestry & Fishing. For Construction, there was a moderately
significant elevation between 5–10 years and 10+ years. This potentially indicates that exposure over
a period of time may have varying effects, with some time periods being more detrimental. It must be
noted that, with liver injury being multifactorial, lead may not play the largest role and other factors
such as alcohol use, drug use, and genetic background, also contribute to liver injury [27].
4.2. On Lead and Its Role in Altering Hepatobiliary Clinical Makers
According to Lanphear and co-authors, low-level environmental lead exposure is a factor for
diseases such as cardiovascular disease [28,29]. It also seems to potentially affect the hepatic and biliary
system. In the United States, low-level lead exposure is the norm in many communities because of the
legacy of lead exposure, which keeps populations continuously exposed. In addition, the workplace
serves as the primary avenue by which adults are exposed.
Results from this study point to the fact that participants at different binary levels of exposure have
varied presentations. For example, when lead was divided at 2 µg/dL for less-exposed/exposed, those
exposed to lead were more likely to have high ALP (adjusted odds ratio (OR) 1.93; 95% confidence
interval (CI) 1.42, 2.61) and GGT (adjusted OR 1.24; 95% CI 1.08, 1.42).
At the 5 µg/dL level, those exposed to lead were moderately significantly more likely to have
higher ALP (adjusted OR 2.90; 95% CI 1.18, 7.08), and GGT (adjusted OR 1.48; 95% CI 1.12, 1.95) levels.
At the 10 µg/dL level those exposed to lead were more likely to have higher GGT levels (adjusted OR
2.19; 95% CI 1.34, 3.56). This may indicate lead’s effects at different degrees of exposure with damage
being manifested differently at various cutoffs.
This study found positive significant associations between BLL and ALP, GGT and total bilirubin.
Regarding the exposed and less-exposed, for AST there was a significant elevation from quartile 1
to quartile 2. For ALP there was a significant elevation from quartile 1 to quartile 2 and 3. Finally,
for GGT there was a significant elevation from quartile 1 to quartiles 2 and 3. This speaks to increasing
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lead dose producing worse outcomes and that hepatobiliary clinical makers at different degrees of
exposure are potential predators of poor health outcomes and all-cause mortality as they reflect liver
injury and oxidative stress.
The effects of lead on AST and ALT have been demonstrated in the literature. Onyeneke and
co-authors [24] in their study of 86 adult Nigerians who were occupationally exposed to lead and 30
control subjects who were not exposed to lead (while looking to understand occupational exposure to
lead in Nigeria and its relation with impairment of liver function), found that the activity of ALT and
AST were significantly elevated in occupationally exposed workers as compared to controls, whereas
there was no statistically significant changes in serum total bilirubin.
Regarding GGT and its association with BLL in adults, Lee and co-authors in an analysis
of NHANES III found associations between blood lead and GGT in adults [30]. Al-Neamy and
co-authors [18] in their study found mean AST levels to be elevated in the exposed (31.8 ± 12.3)
as compared to mean AST levels of the less-exposed (30.7 ± 13.2), however, the means were not
statistically significantly different.
For ALT, they found levels to be slightly elevated in the less-exposed (33.5 ± 24.2) as compared
to the exposed (33.2 ± 27.6) but the difference was again not statistically significant. The authors
found the mean total bilirubin levels to be more elevated in the exposed (0.75 ± 0.3) compared to the
less-exposed (0.70 ± 0.19) but these differences were not statistically significant. In addition, they
found GGT to be elevated in the exposed (36.3 ± 35.2) as compared to the less-exposed (31.36 ± 17.9),
but the difference was not statistically significant. Finally, they found ALP to be more elevated in the
exposed (84.3 ± 24.6) as compared to the less-exposed (76.1 ± 20.5) with the difference proving to be
statistically significant. Thus, the results of our study, which demonstrates a statistically significant
difference in mean GGT levels between the differentially exposed individuals, contradict those of
Al-Neamy and co-authors’ study while the positive association found in regression affirms that of Lee
and co-authors’ study. However, our study finding of a significant difference in the means of ALP
between the varying degrees of exposure affirms the results of Al-Neamy and co-authors’ study.
An observation of the results of our study and those of the others show the uniqueness of our
study, given that it looked at larger sample sizes as compared to the non-NHANES studies. Another
difference is the fact that, the studies by Onyeneke [24] and Al-Neamy [18] were in Nigeria and the
UAE, whereas our analysis was performed on populations in the United States.
Finally, our results regarding ALP, GGT, and total bilirubin indicate significant lead induced
pathology in the extrahepatic biliary system, potentially regarding cholestasis, as compared to the
intrahepatic system, as there are significant elevations and associations in the aforementioned enzymes
as compared to ALT and AST. It should be noted that even though the results regarding ALP and GGT
would strongly suggest lead induced hepatobiliary dysfunction, elevated GGT activity may occur in
acute and chronic pancreatitis or even prostatic adenocarcinoma with elevated ALP also occurring
in other pathology, indicating that using the absence of skeletal diseases and the absence of placenta
induced elevations and pairing it with elevated ALP enzymatic activity should not be considered
a clinically specific sign of hepatobiliary dysfunction [31].
4.3. Limitations of Study and Future Works
Measurement of BLLs does not indicate longer-term exposure, rather, it is indicative of recent
lead exposure as well as lead that has been mobilized from bone or other tissue sources with no ability
to distinguish between both. Measuring of bone lead levels, particularly tibia lead level, via K-Shell
X-Ray Fluorescence (KSXF) would have provided more information on length of exposure as bone
lead levels are indicative of long-term cumulative exposure to lead. Both the BLLs and bone lead
levels taken together would have provided the best and most comprehensive view of the participant’s
exposure [32]. In attempting to overcome the limitation of long-term exposure, length of time at
occupation was analyzed and seeing the differences in health outcomes overtime helped to give hints
on the manifestations of long term exposure.
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Finally, owing to the inability to adjust for covariates in the occupational analysis, and the inability
to perform regression analysis on lead exposed occupations due to inadequate data in all strata for any
of exposed occupations, future works should look at larger occupational databases. This will enable
the evaluation of the significances found here in adjusted models for lead exposed occupations.
5. Conclusions
Lead exposure was significantly associated with adverse hepatobiliary clinical makers, with
higher exposure resulting in worse outcomes. Looking at various degrees of exposure, lead increased
the odds of elevated hepatobiliary clinical markers. Finally, occupational exposure may play a role
in these outcomes. These findings add to the growing body of evidence that lead exposure may be
an important risk factor for liver and gallbladder dysfunction in exposed populations. Based on
the above discussion, it is suggested that a critical need exists to test novel interventions capable of
mitigating and subsequently eliminating the impact of lead on hepatobiliary health. Studies aimed
at interventions that mitigate and/or eliminate the harmful effects of lead on the environment and
on human health are still required for successful optimal health management. This is key as Gould
and co-authors note that every dollar invested in lead paint hazard prevention yielded $17 to $221
return or a total saving of $181–$269 billion per year [33]. Finally, this study’s cross-sectional nature
means that it portrays a snapshot in time. A longitudinal study may yield more in-depth results as
people’s unique circumstances (finances, family, etc.) change, which may result in gaining access to
necessary knowledge and preventative measures about lead exposure and hence seeking avenues to
mitigate the effects of it on their health and environment. Ultimately, this work can be used to improve
public health by working to limit exposure to higher doses as this seems to be associated with worse
liver/biliary injury but, as injury occurs at even low exposure levels it must be emphasized that no
level of exposure is safe. Future works should look at individual, community, state, and regional-level
risk factors of lead exposure on hepatobiliary clinical markers to better understand how these factors
may differentially alter them and the impact at all four levels.
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